Application 761137
- Type
- BLA
- Sponsor
- ASTELLAS
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761137 | Padcev | enfortumab vedotin-ejfv | 351(a) | Rx | 2026-09-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PADCEV | ENFORTUMAB VEDOTIN-EJFV | INJECTABLE;INJECTION | 20MG/VIAL | No | No |
| 002 | PADCEV | ENFORTUMAB VEDOTIN-EJFV | INJECTABLE;INJECTION | 30MG/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PADCEV EJFV | ENFORTUMAB VEDOTIN | SEAGEN INC. | b5631d3e-4604-4363-8f20-11dfc5a4a8ed | 2026-08-04 | Boxed warning, Warnings, Adverse reactions | BLA761137 51144-030 51144-020 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-020 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | Seattle Genetics, Inc. | BLA | Current |
| 51144-030 | PADCEV | ENFORTUMAB VEDOTIN | SEAGEN INC. | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 84281 | SUPPL | 2025-11-24 |
| 84288 | SUPPL | 2025-11-21 |
| 81386 | SUPPL | 2025-03-03 |
| 81382 | SUPPL | 2025-02-28 |
| 77066 | SUPPL | 2023-12-19 |
| 77065 | SUPPL | 2023-12-19 |
| 76864 | SUPPL | 2023-12-15 |
| 76863 | SUPPL | 2023-12-15 |
| 74027 | SUPPL | 2023-04-19 |
| 74026 | SUPPL | 2023-04-19 |
| 73960 | SUPPL | 2023-04-07 |
| 73949 | SUPPL | 2023-04-04 |
| 73948 | SUPPL | 2023-04-04 |
| 73941 | SUPPL | 2023-04-03 |
| 72521 | SUPPL | 2022-11-01 |
| 72508 | SUPPL | 2022-10-31 |
| 68056 | SUPPL | 2021-07-13 |
| 68055 | SUPPL | 2021-07-13 |
| 68039 | SUPPL | 2021-07-09 |
| 68038 | SUPPL | 2021-07-09 |
| 66868 | SUPPL | 2021-03-25 |
| 66838 | SUPPL | 2021-03-23 |
| 61536 | ORIG | 2020-01-08 |
| 61359 | ORIG | 2019-12-20 |
| 61344 | ORIG | 2019-12-19 |